VS
Compare iShares Global Healthcare Index ETF (XHC) vs BMO Global Health Care Fund Active ETF Series (ZGHC) to find the best fit for your portfolio. XHC and ZGHC provide the same top sector exposures: Healthcare, Consumer Non-Cyclicals, and Consumer Cyclicals. When evaluating costs, XHC features a management fee (MER) of 0.63%, compared to 1.02% for ZGHC. Performance-wise, XHC has returned 6.07% year-to-date with -$47 M in net flows, whereas ZGHC is at 7.31% with +$14 M. Use the comparison tool below to benchmark these funds across top 10 holdings, yield, sector weights and historical returns.
NAV Performance and Flows
Key Data
Compare
XHC
ZGHC
| AuM | $541.04 M | $17.06 M |
| Management Fees | 0.63% | 1.02% |
| Exp. ratio | 0.66% | 0.82% |
| Tracking Difference | -0.81% | - |
Historical performance and flows
As of July 29, 2026
| 1M | 3M | YTD | 1Y | 3Y | ||
|---|---|---|---|---|---|---|
| Perf. | XHC | +2.96% | +14.36% | +6.07% | +20.22% | +20.11% |
ZGHC | +0.16% | +17.48% | +7.31% | +20.84% | +32.12% | |
| Flows | XHC | +$11 M | -$6 M | -$47 M | -$10 M | -$91 M |
ZGHC | +$7 M | +$8 M | +$14 M | -$105 M | +$16 M |
XHC vs ZGHC exposure
Countries
XHC
USA
69.39%
Switzerland
10.35%
Other
20.26%
ZGHC
USA
79.11%
Switzerland
9.37%
Other
11.52%
Sectors
XHC
Healthcare
96.86%
ZGHC
Healthcare
97.85%
As of July 29, 2026
Top 10 Holdings
XHC
Eli Lilly & Co.
10.91%
Johnson & Johnson
7.03%
AbbVie, Inc.
5.11%
UnitedHealth Group, Inc.
4.39%
Merck & Co., Inc.
4.11%
AstraZeneca PLC
3.76%
Roche Holding AG
3.75%
Novartis AG
3.72%
Amgen, Inc.
2.53%
Thermo Fisher Scientific, Inc.
2.41%
ZGHC
Eli Lilly & Co.
11.63%
Johnson & Johnson
7.56%
UnitedHealth Group, Inc.
7.43%
Merck & Co., Inc.
6.51%
AbbVie, Inc.
5.90%
AstraZeneca PLC
4.89%
argenx SE
4.40%
Novartis AG
3.87%
Gilead Sciences, Inc.
3.25%
BrightSpring Health Services, Inc.
3.11%
Diversification
XHC
Total weight of top 10 holdings out of 111 total
47.72%
ZGHC
Total weight of top 10 holdings out of 119 total
58.55%
Characteristics
Compare
XHC
ZGHC
| Provider | iShares | BMO |
| Management | Passively managed | Actively managed |
| Benchmark | S&P Global 1200 Health Care CAD Hedged Net Total Return Index - CAD | - |
| Replication Method | ||
| Asset Class | Equity | Equity |
| Dividend Policy | Distributing | Distributing |
| Trailing 12m distribution yield | 1.82% | 0.00% |
| Meets ESG criteria | No | No |
| Inception Date | April 12, 2011 | June 26, 2023 |
Frequently asked questions about XHC and ZGHC
Which ETF has performed better year to date: XHC or ZGHC?
As of July 29, 2026, XHC has returned 6.07% year to date, while ZGHC has returned 7.31%. ZGHC is ahead on YTD performance.
Which ETF is larger by assets under management: XHC or ZGHC?
As of July 29, 2026, XHC manages $541.04 M in assets, while ZGHC manages $17.06 M. XHC is the larger fund by AUM.
How are XHC and ZGHC managed?
XHC is passively managed by iShares. It tracks the S&P Global 1200 Health Care CAD Hedged Net Total Return Index - CAD benchmark. ZGHC is actively managed by BMO. It does not track an index.
What sectors do XHC and ZGHC emphasize?
XHC is most exposed to Healthcare, Consumer Non-Cyclicals, and Consumer Cyclicals. ZGHC is most exposed to Healthcare, Consumer Non-Cyclicals, and Consumer Cyclicals.
Which ETF is attracting more investor flows: XHC or ZGHC?
Year to date, XHC has seen -$47.21 M in net flows, compared with +$13.52 M for ZGHC. ZGHC has attracted more net investor money so far.
How do the fees of XHC and ZGHC compare?
XHC has an expense ratio of 0.66%, while ZGHC has an expense ratio of 0.82%.
What are the top holdings of XHC and ZGHC?
XHC's largest holdings include Eli Lilly & Co., Johnson & Johnson, and AbbVie, Inc.. ZGHC's top holdings include Eli Lilly & Co., Johnson & Johnson, and UnitedHealth Group, Inc..
Which ETF is more diversified: XHC or ZGHC?
XHC holds 110 securities, while ZGHC holds 117. On holdings count, ZGHC is the more diversified portfolio.
Recent articles about XHC and ZGHC
The ETF Market Canada is brought to you by Cboe in partnership with Trackinsight SA who is providing all the data, analysis and editorial content on this site. Unless explicitly stated as such, any information that you receive is not real-time.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.